APO Research

APO RESEARCH · REPORT

Biomedical CRO

Selected research

Industry Growth & Trends

Global Biomedical CRO Industry Growth and Trends Forecast to 2032

Market perspective

According to APO Research, the global Biomedical CRO market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Biomedical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Biomedical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Biomedical CRO is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Biomedical CRO market include Charles River, Wuxi AppTec, Labcorp, Eurofins Scientific, PPD, ICON Plc, Pharmaron, Inotiv and ChemPartner, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Biomedical CRO market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Biomedical CRO market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Biomedical CRO market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Biomedical CRO.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Biomedical CRO market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Biomedical CRO Market by Company

Charles River

Wuxi AppTec

Labcorp

Eurofins Scientific

PPD

ICON Plc

Pharmaron

Inotiv

ChemPartner

JOINN Lab

EVOTEC

Medicilon

Crown Bioscience

Champion Oncology

Biomedical CRO Segment by Type

Preclinical CRO

Clinical CRO

Biomedical CRO Segment by Application

Biological Industry

Medical Industry

Biomedical CRO Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomedical CRO market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Biomedical CRO and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomedical CRO.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Biomedical CRO companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Biomedical CRO Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Biomedical CRO Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Biomedical CRO Market Share by Region (2021-2026) Table 4. Global Biomedical CRO Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Biomedical CRO Market Share by Region (2027-2032) Table 6. Global Biomedical CRO Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Biomedical CRO Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Biomedical CRO Market Size Share by Type (2021-2026) Table 9. Global Biomedical CRO Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Biomedical CRO Market Size Share Forecasted by Type (2027-2032) Table 11. North America Biomedical CRO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Biomedical CRO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Biomedical CRO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Biomedical CRO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Biomedical CRO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Biomedical CRO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Biomedical CRO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Biomedical CRO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Biomedical CRO Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Biomedical CRO Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Biomedical CRO Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Biomedical CRO Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Biomedical CRO Market Size Share by Application (2021-2026) Table 24. Global Biomedical CRO Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Biomedical CRO Market Size Share Forecasted by Application (2027-2032) Table 26. North America Biomedical CRO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Biomedical CRO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Biomedical CRO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Biomedical CRO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Biomedical CRO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Biomedical CRO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Biomedical CRO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Biomedical CRO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Biomedical CRO Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Biomedical CRO Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Biomedical CRO Industry Trends Table 37. Biomedical CRO Industry Drivers Table 38. Biomedical CRO Industry Opportunities and Challenges Table 39. Biomedical CRO Industry Restraints Table 40. Global Biomedical CRO Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Biomedical CRO Revenue Market Share by Company (2021-2026) Table 42. Global Biomedical CRO Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Biomedical CRO Key Company Headquarters & Area Served Table 44. Global Biomedical CRO Company, Product Type & Application Table 45. Global Biomedical CRO Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Biomedical CRO by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Charles River Company Information Table 49. Charles River Business Overview Table 50. Charles River Biomedical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Charles River Biomedical CRO Product Portfolio Table 52. Charles River Recent Development Table 53. Wuxi AppTec Company Information Table 54. Wuxi AppTec Business Overview Table 55. Wuxi AppTec Biomedical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Wuxi AppTec Biomedical CRO Product Portfolio Table 57. Wuxi AppTec Recent Development Table 58. Labcorp Company Information Table 59. Labcorp Business Overview Table 60. Labcorp Biomedical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Labcorp Biomedical CRO Product Portfolio Table 62. Labcorp Recent Development Table 63. Eurofins Scientific Company Information Table 64. Eurofins Scientific Business Overview Table 65. Eurofins Scientific Biomedical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Eurofins Scientific Biomedical CRO Product Portfolio Table 67. Eurofins Scientific Recent Development Table 68. PPD Company Information Table 69. PPD Business Overview Table 70. PPD Biomedical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. PPD Biomedical CRO Product Portfolio Table 72. PPD Recent Development Table 73. ICON Plc Company Information Table 74. ICON Plc Business Overview Table 75. ICON Plc Biomedical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. ICON Plc Biomedical CRO Product Portfolio Table 77. ICON Plc Recent Development Table 78. Pharmaron Company Information Table 79. Pharmaron Business Overview Table 80. Pharmaron Biomedical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Pharmaron Biomedical CRO Product Portfolio Table 82. Pharmaron Recent Development Table 83. Inotiv Company Information Table 84. Inotiv Business Overview Table 85. Inotiv Biomedical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Inotiv Biomedical CRO Product Portfolio Table 87. Inotiv Recent Development Table 88. ChemPartner Company Information Table 89. ChemPartner Business Overview Table 90. ChemPartner Biomedical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. ChemPartner Biomedical CRO Product Portfolio Table 92. ChemPartner Recent Development Table 93. JOINN Lab Company Information Table 94. JOINN Lab Business Overview Table 95. JOINN Lab Biomedical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. JOINN Lab Biomedical CRO Product Portfolio Table 97. JOINN Lab Recent Development Table 98. EVOTEC Company Information Table 99. EVOTEC Business Overview Table 100. EVOTEC Biomedical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. EVOTEC Biomedical CRO Product Portfolio Table 102. EVOTEC Recent Development Table 103. Medicilon Company Information Table 104. Medicilon Business Overview Table 105. Medicilon Biomedical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Medicilon Biomedical CRO Product Portfolio Table 107. Medicilon Recent Development Table 108. Crown Bioscience Company Information Table 109. Crown Bioscience Business Overview Table 110. Crown Bioscience Biomedical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Crown Bioscience Biomedical CRO Product Portfolio Table 112. Crown Bioscience Recent Development Table 113. Champion Oncology Company Information Table 114. Champion Oncology Business Overview Table 115. Champion Oncology Biomedical CRO Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Champion Oncology Biomedical CRO Product Portfolio Table 117. Champion Oncology Recent Development Table 118. North America Biomedical CRO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 119. North America Biomedical CRO Market Size by Country (2021-2026) & (US$ Million) Table 120. North America Biomedical CRO Market Share by Country (2021-2026) Table 121. North America Biomedical CRO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 122. North America Biomedical CRO Market Share Forecast by Country (2027-2032) Table 123. Europe Biomedical CRO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 124. Europe Biomedical CRO Market Size by Country (2021-2026) & (US$ Million) Table 125. Europe Biomedical CRO Market Share by Country (2021-2026) Table 126. Europe Biomedical CRO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 127. Europe Biomedical CRO Market Share Forecast by Country (2027-2032) Table 128. Asia-Pacific Biomedical CRO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. Asia-Pacific Biomedical CRO Market Size by Country (2021-2026) & (US$ Million) Table 130. Asia-Pacific Biomedical CRO Market Share by Country (2021-2026) Table 131. Asia-Pacific Biomedical CRO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. Asia-Pacific Biomedical CRO Market Share Forecast by Country (2027-2032) Table 133. Latin America Biomedical CRO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Latin America Biomedical CRO Market Size by Country (2021-2026) & (US$ Million) Table 135. Latin America Biomedical CRO Market Share by Country (2021-2026) Table 136. Latin America Biomedical CRO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Latin America Biomedical CRO Market Share Forecast by Country (2027-2032) Table 138. Middle East & Africa Biomedical CRO Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Middle East & Africa Biomedical CRO Market Size by Country (2021-2026) & (US$ Million) Table 140. Middle East & Africa Biomedical CRO Market Share by Country (2021-2026) Table 141. Middle East & Africa Biomedical CRO Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Middle East & Africa Biomedical CRO Market Share Forecast by Country (2027-2032) Table 143. Research Programs/Design for This Report Table 144. Authors List of This Report Table 145. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Biomedical CRO Product Image Figure 3. Global Biomedical CRO Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Biomedical CRO Market Size (2021-2032) & (US$ Million) Figure 5. Global Biomedical CRO Market Share by Region: 2025 VS 2032 Figure 6. Global Biomedical CRO Market Share by Region (2021-2032) Figure 7. North America Biomedical CRO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Biomedical CRO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Biomedical CRO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Biomedical CRO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Biomedical CRO Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Preclinical CRO Image Figure 13. Global Preclinical CRO Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Clinical CRO Image Figure 15. Global Clinical CRO Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Biomedical CRO Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Biomedical CRO Market Share by Type 2025 VS 2032 Figure 18. North America Biomedical CRO Market Size Share by Type (2021-2032) Figure 19. Europe Biomedical CRO Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Biomedical CRO Market Size Share by Type (2021-2032) Figure 21. Latin America Biomedical CRO Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Biomedical CRO Market Size Share by Type (2021-2032) Figure 23. Biological Industry Image Figure 24. Global Biological Industry Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Medical Industry Image Figure 26. Global Medical Industry Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Global Biomedical CRO Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Biomedical CRO Market Share by Application 2025 VS 2032 Figure 29. North America Biomedical CRO Market Size Share by Application (2021-2032) Figure 30. Europe Biomedical CRO Market Size Share by Application (2021-2032) Figure 31. Asia-Pacific Biomedical CRO Market Size Share by Application (2021-2032) Figure 32. Latin America Biomedical CRO Market Size Share by Application (2021-2032) Figure 33. Middle East and Africa Biomedical CRO Market Size Share by Application (2021-2032) Figure 34. Global Top 5 and 10 Biomedical CRO Players Market Share by Revenue in 2025 Figure 35. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 36. North America Biomedical CRO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 37. North America Biomedical CRO Market Share by Country: 2021 VS 2025 VS 2032 Figure 38. North America Biomedical CRO Market Share by Country (2021-2032) Figure 39. Europe Biomedical CRO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 40. Europe Biomedical CRO Market Share by Country: 2021 VS 2025 VS 2032 Figure 41. Europe Biomedical CRO Market Share by Country (2021-2032) Figure 42. Asia-Pacific Biomedical CRO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. Asia-Pacific Biomedical CRO Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. Asia-Pacific Biomedical CRO Market Share by Country (2021-2032) Figure 45. Latin America Biomedical CRO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Latin America Biomedical CRO Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Latin America Biomedical CRO Market Share by Country (2021-2032) Figure 48. Middle East & Africa Biomedical CRO Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Middle East & Africa Biomedical CRO Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Middle East & Africa Biomedical CRO Market Share by Country (2021-2032) Figure 51. Years Considered Figure 52. Research Process Figure 53. Key Executives Interviewed

Scope & coverage.

Types
  • Preclinical CRO
  • Clinical CRO
Applications
  • Biological Industry
  • Medical Industry
Companies covered
  • Charles River
  • Wuxi AppTec
  • Labcorp
  • Eurofins Scientific
  • PPD
  • ICON Plc
  • Pharmaron
  • Inotiv
  • ChemPartner
  • JOINN Lab
  • EVOTEC
  • Medicilon
  • Crown Bioscience
  • Champion Oncology

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Biomedical CRO Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Biomedical CRO Market Size by Region (2021-2032)
  5. 1.4.1 Global Biomedical CRO Market Size by Region (2021-2026)
  6. 1.4.2 Global Biomedical CRO Market Size by Region (2027-2032)
  7. 1.5 Key Regions Biomedical CRO Market Size (2021-2032)
  8. 1.5.1 North America Biomedical CRO Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Biomedical CRO Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Biomedical CRO Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Biomedical CRO Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Biomedical CRO Market Size Growth Rate (2021-2032)
2 Biomedical CRO Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Preclinical CRO
  3. 2.1.2 Clinical CRO
  4. 2.2 Global Biomedical CRO Market Size by Type
  5. 2.2.1 Global Biomedical CRO Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Biomedical CRO Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Biomedical CRO Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Biomedical CRO Market Size by Regions
  9. 2.3.1 North America Biomedical CRO Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Biomedical CRO Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Biomedical CRO Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Biomedical CRO Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Biomedical CRO Market Size Breakdown by Type (2021-2026)
3 Biomedical CRO Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Biological Industry
  3. 3.1.2 Medical Industry
  4. 3.2 Global Biomedical CRO Market Size by Application
  5. 3.2.1 Global Biomedical CRO Market Size Overview by Application (2021-2032)
  6. 3.2.2 Global Biomedical CRO Historic Market Size Review by Application (2021-2026)
  7. 3.2.3 Global Biomedical CRO Market Size Forecasted by Application (2027-2032)
  8. 3.3 Global Biomedical CRO Market Size by Regions
  9. 3.3.1 North America Biomedical CRO Market Size Breakdown by Application (2021-2026)
  10. 3.3.2 Europe Biomedical CRO Market Size Breakdown by Application (2021-2026)
  11. 3.3.3 Asia-Pacific Biomedical CRO Market Size Breakdown by Application (2021-2026)
  12. 3.3.4 South America Biomedical CRO Market Size Breakdown by Application (2021-2026)
  13. 3.3.5 Middle East and Africa Biomedical CRO Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Biomedical CRO Industry Trends
  2. 4.2 Biomedical CRO Industry Drivers
  3. 4.3 Biomedical CRO Industry Opportunities and Challenges
  4. 4.4 Biomedical CRO Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Biomedical CRO Revenue (2021-2026)
  2. 5.2 Global Biomedical CRO Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Biomedical CRO Key Company Headquarters & Area Served
  4. 5.4 Global Biomedical CRO Company, Product Type & Application
  5. 5.5 Global Biomedical CRO Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Biomedical CRO Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Biomedical CRO Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Biomedical CRO Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Charles River
  2. 6.1.1 Charles River Company Information
  3. 6.1.2 Charles River Business Overview
  4. 6.1.3 Charles River Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Charles River Biomedical CRO Product Portfolio
  6. 6.1.5 Charles River Recent Developments
  7. 6.2 Wuxi AppTec
  8. 6.2.1 Wuxi AppTec Company Information
  9. 6.2.2 Wuxi AppTec Business Overview
  10. 6.2.3 Wuxi AppTec Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Wuxi AppTec Biomedical CRO Product Portfolio
  12. 6.2.5 Wuxi AppTec Recent Developments
  13. 6.3 Labcorp
  14. 6.3.1 Labcorp Company Information
  15. 6.3.2 Labcorp Business Overview
  16. 6.3.3 Labcorp Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Labcorp Biomedical CRO Product Portfolio
  18. 6.3.5 Labcorp Recent Developments
  19. 6.4 Eurofins Scientific
  20. 6.4.1 Eurofins Scientific Company Information
  21. 6.4.2 Eurofins Scientific Business Overview
  22. 6.4.3 Eurofins Scientific Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Eurofins Scientific Biomedical CRO Product Portfolio
  24. 6.4.5 Eurofins Scientific Recent Developments
  25. 6.5 PPD
  26. 6.5.1 PPD Company Information
  27. 6.5.2 PPD Business Overview
  28. 6.5.3 PPD Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 PPD Biomedical CRO Product Portfolio
  30. 6.5.5 PPD Recent Developments
  31. 6.6 ICON Plc
  32. 6.6.1 ICON Plc Company Information
  33. 6.6.2 ICON Plc Business Overview
  34. 6.6.3 ICON Plc Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 ICON Plc Biomedical CRO Product Portfolio
  36. 6.6.5 ICON Plc Recent Developments
  37. 6.7 Pharmaron
  38. 6.7.1 Pharmaron Company Information
  39. 6.7.2 Pharmaron Business Overview
  40. 6.7.3 Pharmaron Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Pharmaron Biomedical CRO Product Portfolio
  42. 6.7.5 Pharmaron Recent Developments
  43. 6.8 Inotiv
  44. 6.8.1 Inotiv Company Information
  45. 6.8.2 Inotiv Business Overview
  46. 6.8.3 Inotiv Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Inotiv Biomedical CRO Product Portfolio
  48. 6.8.5 Inotiv Recent Developments
  49. 6.9 ChemPartner
  50. 6.9.1 ChemPartner Company Information
  51. 6.9.2 ChemPartner Business Overview
  52. 6.9.3 ChemPartner Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 ChemPartner Biomedical CRO Product Portfolio
  54. 6.9.5 ChemPartner Recent Developments
  55. 6.10 JOINN Lab
  56. 6.10.1 JOINN Lab Company Information
  57. 6.10.2 JOINN Lab Business Overview
  58. 6.10.3 JOINN Lab Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 JOINN Lab Biomedical CRO Product Portfolio
  60. 6.10.5 JOINN Lab Recent Developments
  61. 6.11 EVOTEC
  62. 6.11.1 EVOTEC Company Information
  63. 6.11.2 EVOTEC Business Overview
  64. 6.11.3 EVOTEC Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 EVOTEC Biomedical CRO Product Portfolio
  66. 6.11.5 EVOTEC Recent Developments
  67. 6.12 Medicilon
  68. 6.12.1 Medicilon Company Information
  69. 6.12.2 Medicilon Business Overview
  70. 6.12.3 Medicilon Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Medicilon Biomedical CRO Product Portfolio
  72. 6.12.5 Medicilon Recent Developments
  73. 6.13 Crown Bioscience
  74. 6.13.1 Crown Bioscience Company Information
  75. 6.13.2 Crown Bioscience Business Overview
  76. 6.13.3 Crown Bioscience Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Crown Bioscience Biomedical CRO Product Portfolio
  78. 6.13.5 Crown Bioscience Recent Developments
  79. 6.14 Champion Oncology
  80. 6.14.1 Champion Oncology Company Information
  81. 6.14.2 Champion Oncology Business Overview
  82. 6.14.3 Champion Oncology Biomedical CRO Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Champion Oncology Biomedical CRO Product Portfolio
  84. 6.14.5 Champion Oncology Recent Developments
7 North America
  1. 7.1 North America Biomedical CRO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Biomedical CRO Market Size by Country (2021-2026)
  3. 7.3 North America Biomedical CRO Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Biomedical CRO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Biomedical CRO Market Size by Country (2021-2026)
  3. 8.3 Europe Biomedical CRO Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Biomedical CRO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Biomedical CRO Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Biomedical CRO Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Biomedical CRO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Biomedical CRO Market Size by Country (2021-2026)
  3. 10.3 South America Biomedical CRO Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Biomedical CRO Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Biomedical CRO Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Biomedical CRO Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research